Explore our latest financial statements, annual reports, and quarterly earnings, along with historical data.
This archive is regularly updated to provide easy access to our financial performance and
strategic plans.
2024
2022
Interim report H1 2022
January – June · Revenues amounted to MSEK 1 965.3 (1 460.9), corresponding to an increase of +35% for the…
2021
Karo Pharma Quarterly report Q3 2021
July – September Revenues amounted to MSEK 738.5 (679.1), corresponding to an increase of +9% for the period. The organic…
Interim report Q2 2021
April – June Revenues amounted to MSEK 747.9 (688.9), corresponding to an increase of +9% for the period. The organic…
Interim report Q1 2021
January – March Revenues amounted to MSEK 713.0 (793.6), corresponding to a decrease of -10% for the period. The organic…
2020
Karo Pharma publishes third-quarter report 2020 and resolves on sale of own shares
Q3, July – September Net sales amounted to MSEK 679.1 (443.7). This corresponds to an increase of 53% for the…
Second-quarter report 2020
Q2, April – June Net sales amounted to MSEK 688.9 (387.4). This corresponds to an increase of 78% for the…
Interim report Q1 2020
January – March Net sales amounted to MSEK 793.6 (420.8). This corresponds to an increase of 89% for the period.…
2019
Interim report January – September 2019
JULY – SEPTEMBER · Net sales amounted to MSEK 443.7 (395.3). This corresponds to an increase of 12% for the…
INTERIM REPORT THE FIRST QUARTER 2019
· Net sales amounted to MSEK 420.8 (267.1). This corresponds to an increase of 58%. The growth is attributable to…